Yeasen Biotechnology (Shanghai) Co., Ltd.
Founded in 2014, Yeasen biotechnology has been focusing on developing and producing reagents for the life science industry including enzymes, qPCR mixes, and NGS-related reagents. Based on our cutting-edge technology and large-scale production capability, Yeasen has developed multiple product lines with hundreds of high-quality products widely used in the industry of cancer immunotherapy, gene- and cell-based therapy, in vitro diagnosis, and biopharmaceutical.